Literature DB >> 27303106

Polysomnographic parameters during non-rapid eye movement sleep predict continuous positive airway pressure adherence.

Tetsurou Hoshino1, Ryujiro Sasanabe2, Kenta Murotani3, Mariko Arimoto1, Shuntaro Inagawa1, Tohru Tanigawa1, Yasue Uchida1, Tetsuya Ogawa1, Hiromi Ueda1, Toshiaki Shiomi2.   

Abstract

The aim of this study was to investigate the potential polysomnographic predictors of CPAP adherence using polysomnographic parameters at the time of obstructive sleep apnea diagnosis that distinguished between REM and NREM sleep. This was a retrospective cross-sectional study of 173 patients. Patients who used CPAP for more than 4 hours per night for at least 70% of nights over a 6-month period were considered to have good adherence. The poor adherence group included those who had used CPAP for 6 months from initiation, but did not fulfill the definition of good adherence or gave up the treatment within 6 months of treatment initiation. Of the 173 participants, 44 patients had good CPAP adherence and 129 patients had poor adherence. Univariate analysis showed that patients with good adherence had significantly higher apnea-hypopnea index during NREM sleep (p = 0.043), oxygen desaturation index during NREM sleep (p = 0.011), and cumulative percentage of time spent at saturations below 90% (CT90) during NREM sleep (p < .001). In multiple logistic regression analysis including all variables, CT90 during NREM sleep was the only factor independently associated with CPAP adherence (odds ratio, 0.693; 95% confidence interval, 0.582-0.824; p <.0001). The area under the receiver-operating characteristic curve of CT90 during NREM sleep was 0.823 (95% confidence interval, 0.745-0.901).Evaluating NREM sleep is important in reliably predicting CPAP adherence using polysomnographic parameters. CT90 during NREM sleep was the best predictor of CPAP adherence.

Entities:  

Keywords:  adherence; continuous positive airway pressure; obstructive sleep apnea; polysomnography

Mesh:

Year:  2016        PMID: 27303106      PMCID: PMC4885819     

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  33 in total

1.  Oral appliance versus continuous positive airway pressure in obstructive sleep apnea syndrome: a 2-year follow-up.

Authors:  Michiel H J Doff; Aarnoud Hoekema; Peter J Wijkstra; Johannes H van der Hoeven; James J R Huddleston Slater; Lambert G M de Bont; Boudewijn Stegenga
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

2.  Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study.

Authors:  Susan Redline; Gayane Yenokyan; Daniel J Gottlieb; Eyal Shahar; George T O'Connor; Helaine E Resnick; Marie Diener-West; Mark H Sanders; Philip A Wolf; Estella M Geraghty; Tauqeer Ali; Michael Lebowitz; Naresh M Punjabi
Journal:  Am J Respir Crit Care Med       Date:  2010-03-25       Impact factor: 21.405

3.  [The effect of nasal continuous positive airway pressure on endothelial function in obstructive sleep apnea-hypopnea syndrome with coronary heart disease].

Authors:  Jin Zhang; Hai Tan; Xue-ning Shi; Xi-wei Zheng; Yu-mei Li; Shou-fen Li; Zi-yun Ma
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2006-03

4.  Changes in upper airway muscle activation and ventilation during phasic REM sleep in normal men.

Authors:  L Wiegand; C W Zwillich; D Wiegand; D P White
Journal:  J Appl Physiol (1985)       Date:  1991-08

5.  Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

Authors:  E Shahar; C W Whitney; S Redline; E T Lee; A B Newman; F J Nieto; G T O'Connor; L L Boland; J E Schwartz; J M Samet
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

Review 6.  Adherence to continuous positive airway pressure treatment for obstructive sleep apnoea: implications for future interventions.

Authors:  Terri E Weaver; Amy M Sawyer
Journal:  Indian J Med Res       Date:  2010-02       Impact factor: 2.375

7.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

8.  Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders.

Authors:  Clete A Kushida; Michael R Littner; Max Hirshkowitz; Timothy I Morgenthaler; Cathy A Alessi; Dennis Bailey; Brian Boehlecke; Terry M Brown; Jack Coleman; Leah Friedman; Sheldon Kapen; Vishesh K Kapur; Milton Kramer; Teofilo Lee-Chiong; Judith Owens; Jeffrey P Pancer; Todd J Swick; Merrill S Wise
Journal:  Sleep       Date:  2006-03       Impact factor: 5.849

9.  Early CPAP use identifies subsequent adherence to CPAP therapy.

Authors:  Rohit Budhiraja; Sairam Parthasarathy; Christopher L Drake; Thomas Roth; Imran Sharief; Pooja Budhiraja; Victoria Saunders; David W Hudgel
Journal:  Sleep       Date:  2007-03       Impact factor: 5.849

10.  Predictors of continuous positive airway pressure adherence.

Authors:  Peter G Catcheside
Journal:  F1000 Med Rep       Date:  2010-09-23
View more
  3 in total

1.  Non-REM sleep-disordered breathing affects performance on the psychomotor vigilance task.

Authors:  Takuro Kitamura; Soichiro Miyazaki; Hiroshi Kadotani; Takashi Kanemura; Harun Bin Sulaiman; Shoko Takeuchi; Takahisa Tabata; Hideaki Suzuki
Journal:  Sleep Breath       Date:  2017-08-14       Impact factor: 2.816

2.  CPAP Adherence Predictors in a Randomized Trial of Moderate-to-Severe OSA Enriched With Women and Minorities.

Authors:  Anna M May; Tarek Gharibeh; Lu Wang; Amanda Hurley; Harneet Walia; Kingman P Strohl; Reena Mehra
Journal:  Chest       Date:  2018-04-21       Impact factor: 9.410

3.  Adherence Index: sleep depth and nocturnal hypoventilation predict long-term adherence with positive airway pressure therapy in severe obstructive sleep apnea.

Authors:  Magdy K Younes; Andrew E Beaudin; Jill K Raneri; Beth J Gerardy; Patrick J Hanly
Journal:  J Clin Sleep Med       Date:  2022-08-01       Impact factor: 4.324

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.